๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cytomegaloviral Infection

Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy NCT04056533Phase 21 site๐Ÿ“ Santander Instituto de Investigaciรณn Marquรฉs de Valdecilla ยท Tests: CMV CTLs Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) NCT03266640Phase 29 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ Indianapolis New York Medical College ยท Tests: viral specific cytotoxic t-lymphocytes Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation. NCT07670468Phase 1, Phase 21 site๐Ÿ“ Seoul LucasBio ยท Tests: LB-DTK-MV CMV-CMI in csCMVi After HSCT NCT07688759n/a1 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Anti-Cytomegalovirus Therapy Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation NCT06916195n/a5 sites๐Ÿ“ Genova๐Ÿ“ Monza๐Ÿ“ Padova MSD Italia S.r.l. Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT NCT07511127Phase 31 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: Maribavir A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture Systemยฎ NCT02007356Phase 21 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: IFN-ฮณ positive selected T-cells Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant NCT03354728Phase 1, Phase 21 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Laboratory Biomarker Analysis, Multi-peptide CMV-Modified Vaccinia Ankara Vaccine Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients NCT07235683Phase 41 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Letermovir, Placebo, Valganciclovir/Ganciclovir CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant NCT06059391Phase 23 sites๐Ÿ“ Duarte๐Ÿ“ Atlanta๐Ÿ“ Boston City of Hope Medical Center ยท Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Granulocyte Colony-Stimulating Factor, Hemaโ€ฆ Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection NCT07635368n/a2 sites๐Ÿ“ Copenhagen๐Ÿ“ Copenhagen Copenhagen University Hospital, Rigshospitalet T Cell Therapy of Opportunistic Cytomegalovirus Infection NCT02982902EARLY Phase 11 site๐Ÿ“ Cleveland Mari Dallas ยท Tests: CMV specific adoptive t-cells Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir NCT05446571Phase 31 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Letermovir, Valacyclovir A Survey of Maribavir Tablets in Participants With Cytomegalovirus Infection NCT06577363n/a1 site๐Ÿ“ Tokyo Takeda ยท Tests: Maribavir Long-Term Outcomes of Children With Congenital CMV in New York State NCT06226558n/a1 site๐Ÿ“ Stony Brook Stony Brook University Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT) NCT06341543NA1 site๐Ÿ“ Grenoble University Hospital, Grenoble ยท Tests: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes)., Communication of the result of the โ€ฆ ATG Individualized Dosing Model in URD-PBSCT. NCT06572462Phase 21 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: individualized ATG dosing strategy R-MVST Cells for Treatment of Viral Infections NCT05183490Phase 11 site๐Ÿ“ New York Columbia University ยท Tests: Rapidly generated virus specific T (R-MVST) cells Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone NCT07225972Phase 32 sites๐Ÿ“ Valhalla๐Ÿ“ Milwaukee New York Medical College ยท Tests: Standard of Care Antiviral medications, Viral CTLs Study Evaluating the Efficacy and Safety of Artesunate NCT06853184Phase 24 sites๐Ÿ“ Boston๐Ÿ“ Rochester๐Ÿ“ Westmead Amivas Inc. ยท Tests: Artesunate, Ganciclovir (GCV) Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis NCT05911503EARLY Phase 11 site๐Ÿ“ Tianjin Tianjin Medical University ยท Tests: 2% Ganciclovir Eye Drops Immunological and Virological Prognostic Markers of Human Cytomegalovirus (HCMV) Congenital Infection in Pregnant Women With Primary HCMV Infection. NCT07477925n/a1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients NCT05708508Phase 31 site๐Ÿ“ Rouen University Hospital, Rouen ยท Tests: ROVALCYTE Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection NCT07383649Phase 21 site๐Ÿ“ Houston The Methodist Hospital Research Institute ยท Tests: Valganciclovir Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) NCT06958796Phase 42 sites๐Ÿ“ Boston๐Ÿ“ Dallas Camille N. Kotton, MD ยท Tests: Cytomegalovirus Immune Globulin Intravenous (Human) monthly for three months A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation NCT06243731n/a25 sites๐Ÿ“ Anderlecht๐Ÿ“ Leuven๐Ÿ“ Tallinn Takeda ยท Tests: No Intervention Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT. NCT07569653Phase 412 sites๐Ÿ“ Beijing๐Ÿ“ Shijiazhuang๐Ÿ“ Zhengzhou WeiShi ยท Tests: CMV-Specific T-cell Guided Letermovir Discontinuation, Standard Letermovir Prophylaxis Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT NCT06812598NA1 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Letermovir (0-24w๏ผ‰, Letermovir (0-14w๏ผ‰ Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation. NCT07685457NA1 site๐Ÿ“ Seoul LucasBio ยท Tests: LB-DTK-MV Observational Study of the Management of Infants With Congenital CMV NCT05855889n/a1 site๐Ÿ“ London St George's, University of London
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy